ArticleNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2025

Comparative effectiveness, safety and persistence of ocrelizumab versus natalizumab in multiple sclerosis: A real-world, multi-center, propensity score-matched study.

Elena Barbuti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.